Fig. 6
From: High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Quality metrics of positive and negative controls across the primary screen for all cell lines. Positive control compounds (Carboplatin, Cisplatin, Doxorubicin, Mitomycin C, Paclitaxel, and Staurosporine) were screened at 10 µM (duplicate wells per plate) and were normalised to 0.2% DMSO control wells. Box and whisker plots show the distribution of the normalised mean per plate cell counts. Outliers are defined as having values > 1.5 × IQR (interquartile range) outside of the 25th to 75th percentile range and are represented in the plot by black dots. Untreated, media only negative controls were also normalised to 0.2% DMSO.
